Inventor · disambiguated record
Yen-Ming Hsu
Also filed as: HSU YEN-MING
30 granted patents·17 pending applications·321 citations·filing 1995–2024
96Inventor score
Top patents by PatentIndex Score
47 records- 0196US9034324B2Anti-BCMA antibodiesKALLED SUSAN L·Filed 2010·Granted May 19, 2015·156 cites·22 claims
- 0295US8784823B2Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereofUCB PHARMA SA·Filed 2012·Granted Jul 22, 2014·38 cites·7 claims
- 0395US8293237B2Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereofBURKLY LINDA C·Filed 2008·Granted Oct 23, 2012·40 cites·19 claims
- 0491US8821883B2Method of treating B cell cancers by administering truncated BAFF receptorsBIOGEN IDEC INC·Filed 2012·Granted Sep 2, 2014·14 cites·28 claims
- 0590US2025282883A1Anti-bcma antibodiesBIOGEN MA INC·Filed 2024·Application pending·0 cites
- 0685US7700317B2Truncated baff receptorsBIOGEN IDEC INC·Filed 2004·Granted Apr 20, 2010·15 cites·43 claims
- 0784US7173046B2CD40:CD154 binding interrupter compounds and use thereof to treat immunological complicationsBIOGEN INC·Filed 2003·Granted Feb 6, 2007·22 cites·6 claims
- 0880US8617545B2Methods for use with BAFF antagonistsHSU YEN-MING·Filed 2006·Granted Dec 31, 2013·8 cites·7 claims
- 0980US2023135399A1Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereofUCB Biopharma SRL·Filed 2022·Application pending·0 cites
- 1079US9321840B2Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereofUCB PHARMA SA·Filed 2014·Granted Apr 26, 2016·2 cites·15 claims
- 1177US9097726B2Methods of evaluating BAFFBIOGEN IDEC INC·Filed 2014·Granted Aug 4, 2015·1 cites·17 claims
- 1277US8685657B2Methods of evaluating BAFFBIOGEN IDEC INC·Filed 2013·Granted Apr 1, 2014·1 cites·19 claims
- 1377US2022213208A1Anti-bcma antibodiesBIOGEN MA INC·Filed 2021·Application pending·0 cites
- 1476US8022182B2Truncated BAFF receptorsBIOGEN IDEC INC·Filed 2010·Granted Sep 20, 2011·2 cites·3 claims
- 1575US8202698B2Methods of evaluating BAFFHSU YEN-MING·Filed 2006·Granted Jun 19, 2012·3 cites·19 claims
- 1673US8415111B2Methods of evaluating BAFFHSU YEN-MING·Filed 2012·Granted Apr 9, 2013·1 cites·4 claims
- 1769US11111307B2Anti-BCMA antibodiesBIOGEN MA INC·Filed 2018·Granted Sep 7, 2021·0 cites·18 claims
- 1868US11647817B2Wearable electronic device and assembling method thereofACER GADGET INC·Filed 2019·Granted May 16, 2023·2 cites·17 claims
- 1966US11801286B2Recombinant intravenous immunoglobulin (RIVIG) compositions and methods for their production and useAb biosciences inc·Filed 2022·Granted Oct 31, 2023·0 cites·15 claims
- 2066US2019233530A1Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereofUCB BIOPHARMA SPRL·Filed 2019·Application pending·0 cites
- 2159US9297810B2CD40L-binding agent based platelet aggregation assaysBIOGEN IDEC INC·Filed 2013·Granted Mar 29, 2016·0 cites·28 claims
- 2258US7087390B2CAIP-like gene familyBIOGEN IDEC INC·Filed 2002·Granted Aug 8, 2006·0 cites·9 claims
- 2358US2017029518A1Anti-bcma antibodiesBIOGEN MA INC·Filed 2016·Application pending·0 cites
- 2458US2016200823A1Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereofUCB PHARMA SA·Filed 2016·Application pending·0 cites
- 2557US10915807B2Electronic system, portable electronic device and counting information updating methodACER INC·Filed 2019·Granted Feb 9, 2021·0 cites·14 claims
- 2656US2015023961A1Methods of modulating immunological responses by administering truncated baff receptorsAMBROSE CHRISTINE·Filed 2014·Application pending·0 cites
- 2755US11769032B2Electronic system, portable electronic device and counting information updating methodACER INC·Filed 2020·Granted Sep 26, 2023·0 cites·18 claims
- 2855US9494597B2Human control antibodies and uses thereforAb biosciences inc·Filed 2013·Granted Nov 15, 2016·0 cites·16 claims
- 2955US2015125460A1Anti-bcma antibodiesBIOGEN IDEC INC·Filed 2015·Application pending·0 cites
- 3055US2014213470A1Methods for use with baff antagonistsGENENTECH INC·Filed 2013·Application pending·0 cites
- 3154US8409810B2Platelet aggregation assays using a CD40L-binding agentHSU YEN-MING·Filed 2006·Granted Apr 2, 2013·0 cites·28 claims
- 3252US8303958B2Method of treating immunological disorders by administering truncated BAFF receptorsAMBROSE CHRISTINE·Filed 2011·Granted Nov 6, 2012·0 cites·19 claims
- 3351US2006172346A1Methods of designing and producing novel compounds having improved binding affinity for CD154 or other trimeric proteinsZHENG ZHONGLI·Filed 2005·Application pending·0 cites
- 3451US2009324602A1Anti-fn14 antibodies and uses thereofBIOGEN IDEC INC·Filed 2009·Application pending·0 cites
- 3550US11304994B2Recombinant intravenous immunoglobulin (rIVIG) compositions and methods for their production and useAb biosciences inc·Filed 2017·Granted Apr 19, 2022·0 cites·20 claims
- 3650US2007249682A1Novel CD40:CD154 binding interruptor compounds and use thereof to treat immunological complicationsZHENG ZHONGLI·Filed 2007·Application pending·0 cites
- 3749US9276164B2Optoelectronic device and method for manufacturing the sameEPISTAR CORP·Filed 2012·Granted Mar 1, 2016·0 cites·23 claims
- 3849US5837844ACAIP-like gene familyBIOGEN INC·Filed 1995·Granted Nov 17, 1998·5 cites·27 claims
- 3949US5641748ACaip-like gene familyBIOGEN INC·Filed 1995·Granted Jun 24, 1997·5 cites·17 claims
- 4048US5656438ACAIP-like gene familyBIOGEN INC·Filed 1995·Granted Aug 12, 1997·5 cites·39 claims
- 4148US2003235861A1Methods for designing and producing novel compounds having improved binding affinity for CD154 or other trimeric proteinsFiled 2003·Application pending·0 cites
- 4245US2017129951A1Novel human control antibodies and uses thereforAb biosciences inc·Filed 2016·Application pending·0 cites
- 4345US2003212025A1Cd154 variantsFiled 2001·Application pending·0 cites
- 4441US2004006208A1Co-crystal structure of monoclonal antibody 5C8 and CD154, and use thereof in drug designFiled 2003·Application pending·0 cites
- 4540US2006003407A1Methods for preparing highly active april ligand polypeptidesBIOGEN IDEC INC·Filed 2005·Application pending·0 cites
- 4637US6171800B1Method of making and binding CAIP polypeptidesBIOGEN INC·Filed 1995·Granted Jan 9, 2001·1 cites·42 claims
- 4731US6423824B1CAIP-like gene familyBIOGEN INC·Filed 1996·Granted Jul 23, 2002·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Yen-Ming Hsu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →